Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects
NCT02537405
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Embolism, Atrial Fibrillation and Venous Thrombosis
Interventions
DRUG:
Rivaroxaban (BAY 59-7939)
DRUG:
Rivaroxaban (Xarelto, BAY 59-7939)
Sponsor
Bayer